Author

Andreas Neubauer

Universitätsklinikum Gießen und MarburgORCID 0000-0002-7606-8760Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrea NistiD· 1 shared Bastian StielowiD· 1 shared Clara SimoniD· 1 shared Florian FinkernageliD· 1 shared Ignasi FornéiD· 1 shared Julie KönneckeiD· 1 shared Lisa Marie WeberiD· 1 shared Merle Geller· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andrea NistORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells

Sabrina Fischer, Lisa Marie Weber, Bastian Stielow, Miriam Frech, Clara Simon, Merle Geller, Julie Könnecke, Florian Finkernagel, Ignasi Forné, Andrea Nist, Uta‐Maria Bauer, Thorsten Stiewe, Andreas Neubauer, Robert Liefke

This study shows IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent excessive inflammation in AML cells, revealing a potential therapeutic target.

Nucleic Acids Research · May 14, 2024Peer-reviewedMolecular Biology